Camurs gets FDA’s green light to kick off phase 3 testing of treatment of acromegaly and neuroendocrine tumors
Camurus will start with the Phase 3 study of once-monthly octreotide subcutaneous depot for treatment of acromegaly CAM2029.
Pharmaceuticals, Biotechnology and Life Sciences
Camurus will start with the Phase 3 study of once-monthly octreotide subcutaneous depot for treatment of acromegaly CAM2029.
Horizon Therapeutics plc (Nasdaq: HZNP) today announced the initiation of a clinical trial evaluating KRYSTEXXA® (pegloticase injection) in combination with methotrexate as a strategy to increase the durability of response for patients living with chronic gout refractory to conventional therapies – also known as uncontrolled gout.
ROCKVILLE, Md.–(BUSINESS WIRE)–#allergies–Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company, announced today the promotion of Teri Heiland, Ph.D.…
MONTGOMERY, Ala.–(BUSINESS WIRE)–Remove the three paragraphs with headings INDICATIONS AND USAGE, PRIMARY HYPERLIPIDEMIA AND MIXED DYSLIPIDEMIA, and LIMITATIONS OF USE…
First-of-their-kind results to enhance patient experience and efficacy of Columbia Care products by further informing and personalizing treatment recommendations to…
DUBLIN–(BUSINESS WIRE)–The “Global Optogenetics Market Growth, Trends, and Forecasts (2019-2024)” report has been added to ResearchAndMarkets.com’s offering. The major factors…
DUBLIN–(BUSINESS WIRE)–The “Market Spotlight: Benign Prostatic Hyperplasia (BPH)” report has been added to ResearchAndMarkets.com’s offering. This Market Spotlight report covers…
OX401 is the second candidate utilizing Onxeo’s proprietary platform of decoy agonists, platON™ OX401 is optimized to be a next-generation…
DUBLIN–(BUSINESS WIRE)–The “Market Spotlight: Sarcoma” report has been added to ResearchAndMarkets.com’s offering. This Market Spotlight report covers the Sarcoma market,…
DUBLIN–(BUSINESS WIRE)–The “Global Market for Regenerative Medicine (RM), 2019” report has been added to ResearchAndMarkets.com’s offering. The Regenerative Medicine (RM)…